Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Canada

Clinical trial NCT02581189 · COMPLETED

Trial details

NCT number: NCT02581189
Sponsor: AbbVie
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Hepatitis C

Start date: 2015-10-13
Primary completion: 2017-12-20
Enrollment: 565

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.